• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 78 of 100
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Leadership
Valeant CEO to Tell Senate Jacking Up Heart Drug Prices Was a ‘Mistake’
By ReutersApril 27, 2016
Here’s How Drug Prices Actually Work
Finance
Here’s How Drug Prices Actually Work
By Lauren Silva LaughlinApril 26, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health
Senate Calls for Former Valeant CFO to Testify at Hearing
By Laura LorenzettiApril 26, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health
This Rare Children’s Disease Drug Is Pitting Patients Against the FDA
By Sy MukherjeeApril 26, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
Health
Valeant Has Named Joseph Papa its New CEO
By ReutersApril 25, 2016
Novartis AG Full Year Results News Conference
Finance
Novartis May Sell Its $14 Billion Stake in Roche to Fuel Acquisitions
By ReutersApril 25, 2016
Apple Starts iPhone 6 Sales In Germany
Tech
U.S. Drops N.Y. Fight with Apple After Gaining Access to iPhone
By ReutersApril 23, 2016
Venter
Health
AstraZeneca Is Launching a Massive Gene Hunt With This Genome Pioneer
By ReutersApril 22, 2016
Perrigo CEO Joe Papa, right, at a charity event in 2013.
Leadership
Valeant Reportedly Wants This Guy as its New CEO
By ReutersApril 22, 2016
This Is the Best Drugstore Stock to Own Now
Finance
This Is the Best Drugstore Stock to Own Now
By Chris TaylorApril 20, 2016
The Two Mercks Are Locking Horns in a Naming Trademark Spat
Health
The Two Mercks Are Locking Horns in a Naming Trademark Spat
By Sy MukherjeeApril 18, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance
AstraZeneca Is Eyeing This San Francisco Drugmaker
By ReutersApril 18, 2016
Apple Again Pushes Back Against Unlocking iPhone in New York Drug Case
Tech
Apple Again Pushes Back Against Unlocking iPhone in New York Drug Case
By ReutersApril 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Valeant Talking to Investment Banks to Weigh Asset Sales
By ReutersApril 15, 2016
Inside of a Gilead Sciences Lab
Health
The FDA Wants Pharma to Ditch its Archaic Drug Making Process
By Sy MukherjeeApril 14, 2016
1...
  • 76
  • 77
  • 78
  • 79
  • 80
...100
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
'Skills nobody can take': Meet a 20-year-old with a 4.5 GPA who skipped college for technical school to land an 'AI-proof' careerplaceholder alt text
By Muskaan ArshadSeptember 22, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.